NEWPORT BEACH, Calif., October 22, 2015 --- Hoag Hospital Foundation announced the establishment of endowed chairs
in Orthopedic Surgery and Urologic Oncology, underscoring Hoag’s
national leadership in innovative treatment and research -- and the critical
role community philanthropy plays in making them possible.
James T. Caillouette, M.D., was named the Joan & Andy Fimiano Endowed
Chair in Orthopedic Surgery. Jeffrey S. Yoshida, M.D., was named the Benjamin
& Carmela Du Endowed Chair in Urologic Oncology.
The gift from Andy and Joan Fimiano recognizes and honors Dr. Caillouette
for his work in health care economics and reform, along with the design
of next-generation hip and knee implants. The gift will enable Dr. Caillouette
-- chief strategy officer of the Hoag Orthopedic Institute -- to expand
outreach, education, research, recruitment and treatment through Hoag’s
Orthopedic Education & Research Institute.
“We are so grateful to have the opportunity to recognize Dr. Caillouette,
one of the finest orthopedic surgeons in the region,” Andy Fimiano
said. “As a result of his leadership and inspiration, Hoag Orthopedic
Institute has become an outstanding national model for orthopedic programs.
Joan and I know Dr. Caillouette will use his endowed chair as a platform
for expanding his research and recruitment and, most important of all,
for improving treatment and outcomes for Hoag’s patients.”
“The goal of our gift is to enable Dr. Caillouette to share his expertise
so that it benefits more people. Basically, we need to clone him,”
Joan Fimiano said with a smile. She and her husband were both treated
several years ago by Dr. Caillouette. In addition to Dr. Caillouette’s
surgical expertise, Joan Fimiano said she was impressed by his skills
as “a good listener who truly puts his patients’ needs and
concerns above everything else.”
“I'm very honored to be named the first chair in orthopedic surgery.
I’ve spent my entire career at Hoag and I’m now in my 28th
year,” Dr. Caillouette said. “When I joined the staff at Hoag,
we performed fewer than 200 joint replacements a year. Today, Hoag Orthopedic
Institute performs thousands of joint replacements every year. I've
had an opportunity to participate, along with my colleagues, in growing
this institution and it has been very rewarding. I have worked with the
Fimianos for many years, and I’m thrilled to represent their generosity
to the community.”
Dr. Yoshida was named the Benjamin & Carmela Du Endowed Chair in Urologic
Oncology, made possible by the Dus’ $2.25 million gift. As program
director of urologic oncology at Hoag Family Cancer Institute, Dr. Yoshida
plays a key role in the growth of site-specific programs for urologic
malignancies, which include prostate, kidney, bladder and testicular cancers.
He also is an expert in robotic surgery and has performed more than 1,900
surgeries to date.
“Dr. Yoshida’s groundbreaking research on preventive medicine
and care gives hope and healing to thousands of people with cancer, and
we’re honored that our gift will help him and Hoag expand his important
work,” Benjamin Du said. Carmela Du added: “We chose to support
an endowment for Dr. Yoshida because not only is he very talented and
forward thinking, but he’s also a visionary in his approach to health
“Being appointed as an endowed chair is one of the highest distinctions
a physician can receive, and I was shocked -- and thrilled -- when I learned
about the Dus’ remarkable gift,” Dr. Yoshida said.
“This gift will allow us to conduct comprehensive urologic cancer
research including clinical trials, with the initial research focusing
on ‘active surveillance’ of prostate cancer,” Dr. Yoshida
continued. “We will be able to offer state of the art imaging, biomarker
testing and a clinical research platform to optimize this approach to
prostate cancer management. This will not only improve our ability to
monitor cancers but it may also alleviate anxiety that men experience
when on active surveillance. The Dus generous gift will take our vision
and make it a reality.”
“We are honored to recognize Dr. Caillouette and Dr. Yoshida as the
newest endowed chairs at Hoag,” said Flynn A. Andrizzi, Ph.D., president
of Hoag Hospital Foundation and senior vice president of Hoag. “Thanks
to the commitment, determination, and the collective power of wonderful
donors like the Fimianos and Dus, we can continue to provide the highest
quality health care to the communities we serve.”
An endowed chair investiture ceremony and white coat processional took
place on Wednesday, Oct. 21 to recognize the appointments of Dr. Yoshida
and Dr. Caillouette and honor the transformational donors Carmela and
Benjamin Du and Joan and Andy Fimiano. The ceremony also celebrated Melvin
Silverstein, M.D., F.A.C.S., holder of the Gross Family Foundation Endowed
Chair in Oncoplastic Breast Surgery which was previously announced and
awarded. In his remarks, Dr. Silverstein recognized and thanked Sue and
Bill Gross for their generosity.
While historically associated with academic institutions, Hoag now has
eleven endowed chair positions that are enabling the organization to expand
and improve programs in cancer, cardiac care, memory loss and cognitive
impairment, neurosciences, cardiovascular surgery, gastrointestinal disease,
diabetes, breast care and women’s health services. Supporting Hoag’s
extraordinary leaders with endowed chairs is a key fundraising priority
of Hoag Promise, Our Campaign to Lead, Innovate & Transform.
ABOUT HOAG HOSPITAL FOUNDATION
Thanks in large part to philanthropy, Hoag has become one of the nation’s
finest health care systems and serves a diverse and growing population.
Hoag Hospital Foundation, the philanthropic arm of Hoag (a separate 501(c)(3)
corporation), is an integral partner in Hoag’s vision to become
a trusted and nationally recognized health care leader. Under the direction
of a volunteer Board of Directors, the Foundation launched Hoag Promise,
Our Campaign to Lead, Innovate &Transform. With a goal of $627 million
by 2020, the promise of the comprehensive campaign is to drive Hoag’s
continued clinical leadership, innovative spirit and transformative potential.
Please visit www.hoaghospitalfoundation.org.
ABOUT HOAG MEMORIAL HOSPITAL PRESBYTERIAN
Hoag is an approximately $1 billion nonprofit, regional health care delivery
network in Orange County, California, that treats more than 25,000 inpatients
and 369,000 outpatients annually. Hoag consists of two acute-care hospitals
– Hoag Hospital Newport Beach, which opened in 1952, and Hoag Hospital
Irvine, which opened in 2010 – in addition to six health centers
and eight urgent care centers. Hoag is a designated Magnet® hospital
by the American Nurses Credentialing Center (ANCC). Hoag offers a comprehensive
blend of health care services that includes five institutes providing
specialized services in the following areas: cancer, heart and vascular,
neurosciences, women’s health, and orthopedics through Hoag’s
affiliate, Hoag Orthopedic Institute, which consists of an orthopedic
hospital and two ambulatory surgical centers. In 2013, Hoag entered into
an alliance with St. Joseph Health to further expand health care services
in the Orange County community, known as St. Joseph Hoag Health. Hoag
has been named one of the Best Regional Hospitals in the U.S. News &
World Report Metro Edition. National Research Corporation has endorsed
Hoag as Orange County’s most preferred hospital for the past 20
consecutive years and, for an unprecedented 20 years, residents of Orange
County have chosen Hoag as one of the county’s best hospitals in
a local newspaper survey. Visit www.hoag.org for more information.
# # #
To download the offical release, please click